Davis's Drug Guide
maraviroc
General
Genetic Implications:
Pronunciation:
ma-ra-vi-rok
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Celsentri
- Selzentry
Ther. Class.
Pharm. Class.
CCR5 co-receptor antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Maraviroc." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/all/maraviroc.
Vallerand AHA, Sanoski CAC, Quiring CC. Maraviroc. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/all/maraviroc. Accessed September 30, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Maraviroc. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/all/maraviroc
Vallerand AHA, Sanoski CAC, Quiring CC. Maraviroc [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 30]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/all/maraviroc.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - maraviroc
ID - 109309
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109309/all/maraviroc
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -
